Oxford Drug Design raised €2.6M in a funding round in May 2022. The company is based in Oxford, UK. Investors in the round: ACF investors, Meltwind Advisory, o2h Ventures and 1 other. Data as of 21 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
